— Know what they know.
Not Investment Advice

PZRXQ OTC

PhaseRx, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -95.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $1169 mcap · 12M float · 0.0020% daily turnover

Cash Flow Trends

Operating Cash Flow
-$10M -64.1% ▼
Capital Expenditures
$171K -50.0% ▼
Free Cash Flow
-$10M -63.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$7M +431.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2014FY2015FY2016
— Operating Activities —
Net Income-$7M-$7M-$20M
Depreciation & Amort.$512K$331K$136K
Stock-Based Comp.$30K$21K$927K
Change in Working Capital-$105K-$150K$201K
Other Non-Cash Items$2M$1M$9M
Operating Cash Flow-$5M-$6M-$10M
— Investing Activities —
Capital Expenditures-$53K-$114K-$171K
Acquisitions (Net)$0$0$0
Investment Purchases$0$0-$5M
Investment Sales$0$0$8M
Other Investing$0$0-$8M
Investing Cash Flow-$53K-$114K-$6M
— Financing Activities —
Net Debt Issuance-$232K$7M$6M
Stock Repurchased$0$0$0
Dividends Paid$0$0$0
Other Financing$0$10K$0
Financing Cash Flow$5M$7M$22M
Net Change in Cash$354K$1M$7M
Cash End of Period$2M$3M$10M
Free Cash Flow-$5M-$6M-$10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms